Medical Research Network Ltd (MRN), the decentralised clinical trials firm, is planning to expand its geographic presence further following a successful private investment round that includes a £3m working capital facility from Shawbrook Bank.
The firm, based in Milton Keynes, Buckinghamshire, is targeting further growth as it aims to enhance its operational reach having already expanded into North America, Europe and Australasia.
It works with some of the largest pharma, biotech and CRO companies in the world, specialising in conducting clinical trial visits in patient’s homes as well as supporting clinical trial sites with specialist nursing resources.
In addition to geographic expansion, the firm is aiming to increase its offerings through further development of its Research & Development capabilities
MRN’s ambitions are being supported through a £3m working capital facility from Shawbrook Bank.
Graham Wylie, MRN’s CEO – which already operates in five of the six key geographies for clinical trials and is currently involved in around 120 projects globally – said: “MRN is a hugely ambitious organisation and these are hugely exciting times for us as we look to take the next step in the firm’s growth strategy. Our aim has always been to make the clinical trials process as efficient as possible by allowing patients to take part from the comfort of their own home, workplace or school. Our HTS services through the current pandemic has not only allowed patients to have access to potential medications they wouldn’t normally be able to access, but we have been fundamental in rescuing multi-million dollar clinical trials that would have collapsed due to the lack of access to hospitals.”